ESR1 and breast cancer: This is a key strength of our study, as our results could represent breast cancers in younger patients, which are known to be more aggressive and characterized by distinct molecular profiles, including lower proportions of ER+ and luminal A subtypes, but higher proportions of luminal B and lower ER gene expression [42].